 |
(1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II) |
|---|---|
| Trade Name | |
| Orphan Indication | Multiple myeloma |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-22 00:00:00 |
| Sponsor | Phosplatin Therapeutics LLC;1350 6th Avenue, 3rd Floor;New York, New York, 10019 |
Related Access Program
AbbVie – Multiple Myeloma
Janssen Research & Development, LLC – Multiple Myeloma
Dana-Farber Cancer Institute – Multiple Myeloma
Bristol-Myers Squibb – Multiple Myeloma
Peking University – Multiple Myeloma
Novartis Pharmaceuticals – Multiple Myeloma
Onyx Pharmaceuticals, Inc., an Amgen subsidiary – Multiple myeloma